SCHEMBL6772019

SCHEMBL6772019

O=S(=O)(Cl)c1cc(OCCc2ccccc2)ccc1Br

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
MAOB P27338 10/20 0.47
MAOA P21397 9/20 0.47
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
FFAR1 O14842 2/20 0.44
MCL1 Q07820 1/20 0.44
BCL2A1 Q16548 1/20 0.44
GPR84 Q9NQS5 1/20 0.44
ACHE P22303 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6772789 0.86 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL12419696 0.77 CA12 (0.52) CA12CA1CA2CA7CA9
SCHEMBL1129039 0.74 MCL1 (0.58) CA12CA1CA2CA7CA9
SCHEMBL31408181 0.74 MCL1 (0.58) CA12CA1CA2CA7CA9
SCHEMBL5679038 0.73 CA1 (0.46) CA12CA1CA2CA7CA9
SCHEMBL12419798 0.72 RHEB (0.55) CA12CA1CA2CA7CA9
SCHEMBL18702745 0.72 CA12 (0.50) CA12CA1CA2CA7CA9
SCHEMBL9456979 0.71 NPC1 (0.80) CA12CA1CA2CA7CA9
SCHEMBL2804046 0.71 L3MBTL1 (0.45) CA12CA1CA2CA9
SCHEMBL20361216 0.70 NPC1 (0.67) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673824-B1 HYPOTENSIVE AGENTS BRISTOL-MYERS SQUIBB CO. 2004-01-06 US disclosed
US-6107320-A Phenyl sulfonamide endothelin antagonists BRISTOL-MYERS SQUIBB CO. (US) 2000-08-22 US disclosed
US-5514696-A Phenyl sulfonamide endothelin antagonists BRISTOL-MYERS SQUIBB CO. (US) 1996-05-07 US disclosed